Treatment of autoimmune liver disease: current and future therapeutic options
- 19 February 2013
- journal article
- Published by SAGE Publications in Therapeutic Advances in Chronic Disease
- Vol. 4 (3) , 119-141
Abstract
Autoimmune liver disease spans three predominant processes, from the interface hepatitis of autoimmune hepatitis to the lymphocytic cholangitis of primary biliary cirrhosis, and finally the obstructive fibrosing sclerotic cholangiopathy of primary sclerosing cholangitis. Although all autoimmune in origin, they differ in their epidemiology, presentation and response to immunosuppressive therapy and bile acid based treatments. With an ongoing better appreciation of disease aetiology and pathogenesis, treatment is set ultimately to become more rational. We provide an overview of current and future therapies for patients with autoimmune liver disease, with an emphasis placed on some of the evidence that drives current practice.Keywords
This publication has 179 references indexed in Scilit:
- Towards common denominators in primary biliary cirrhosis: The role of IL-12Journal of Hepatology, 2012
- High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing CholangitisAmerican Journal of Gastroenterology, 2011
- Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitisDigestive and Liver Disease, 2011
- Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosisNature Genetics, 2011
- Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activityHepatology, 2010
- Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor β receptor type II mice #Hepatology, 2009
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #Hepatology, 2009
- Ursodeoxycholic acid for primary biliary cirrhosis2008
- A Prospective Trial of Colchicine for Primary Biliary CirrhosisNew England Journal of Medicine, 1986
- Severe chronic active liver diseaseDigestive Diseases and Sciences, 1977